Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Obesity in Adolescents and Youth: The Case for and against Bariatric Surgery.

Khattab A, Sperling MA.

J Pediatr. 2019 Apr;207:18-22. doi: 10.1016/j.jpeds.2018.11.058. Epub 2019 Jan 7. No abstract available.

PMID:
30626484
2.

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, Sperling MA, Codner E.

Pediatr Diabetes. 2018 Oct;19 Suppl 27:155-177. doi: 10.1111/pedi.12701. No abstract available.

PMID:
29900641
3.

Fluid Composition, Infusion Rate, and Brain Injury in Diabetic Ketoacidosis.

Sperling MA.

N Engl J Med. 2018 Jun 14;378(24):2336-2338. doi: 10.1056/NEJMe1806017. No abstract available.

PMID:
29897856
4.

Coming of age: A time for transition.

Sperling MA.

Pediatr Diabetes. 2017 Dec;18(8):685. doi: 10.1111/pedi.12593. No abstract available.

PMID:
29130650
5.

Childhood diabetes mellitus: Advances & challenges.

Menon RK, Thomas IH, Sperling MA.

Indian J Med Res. 2016 Nov;144(5):641-644. doi: 10.4103/ijmr.IJMR_1768_16. No abstract available.

6.

Auditing and standardising care for young people with diabetes: beginning a process to improve outcomes.

Sperling MA.

Med J Aust. 2017 Feb 20;206(3):118-119. No abstract available.

PMID:
28208041
7.

Diabetes: Recurrent DKA - for whom the bell tolls.

Sperling MA.

Nat Rev Endocrinol. 2016 Oct;12(10):562-4. doi: 10.1038/nrendo.2016.137. Epub 2016 Aug 26. No abstract available.

PMID:
27564715
8.

Traditional and novel aspects of the metabolic actions of growth hormone.

Sperling MA.

Growth Horm IGF Res. 2016 Jun;28:69-75. doi: 10.1016/j.ghir.2015.06.005. Epub 2015 Jun 9.

PMID:
26194064
9.

Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children.

Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, Levitsky LL, Murad MH, Rozance PJ, Simmons RA, Sperling MA, Weinstein DA, White NH, Wolfsdorf JI; Pediatric Endocrine Society.

J Pediatr. 2015 Aug;167(2):238-45. doi: 10.1016/j.jpeds.2015.03.057. Epub 2015 May 6. No abstract available.

10.

Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management.

Stanley CA, Rozance PJ, Thornton PS, De Leon DD, Harris D, Haymond MW, Hussain K, Levitsky LL, Murad MH, Simmons RA, Sperling MA, Weinstein DA, White NH, Wolfsdorf JI.

J Pediatr. 2015 Jun;166(6):1520-5.e1. doi: 10.1016/j.jpeds.2015.02.045. Epub 2015 Mar 25. Review. No abstract available.

11.
12.

Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice.

Fan Y, Fang X, Tajima A, Geng X, Ranganathan S, Dong H, Trucco M, Sperling MA.

Front Endocrinol (Lausanne). 2014 Dec 18;5:218. doi: 10.3389/fendo.2014.00218. eCollection 2014.

13.

ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state.

Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, Lee WW, Mungai LN, Rosenbloom AL, Sperling MA, Hanas R; International Society for Pediatric and Adolescent Diabetes.

Pediatr Diabetes. 2014 Sep;15 Suppl 20:154-79. doi: 10.1111/pedi.12165. Epub 2014 Jul 12. No abstract available.

PMID:
25041509
14.

Clinical review: Diabetes in the adolescent: transitional issues.

Lyons SK, Libman IM, Sperling MA.

J Clin Endocrinol Metab. 2013 Dec;98(12):4639-45. doi: 10.1210/jc.2013-2890. Epub 2013 Oct 23. Review.

15.

New insights and new conundrums in neonatal hypoglycemia: enigmas wrapped in mystery.

Sperling MA.

Diabetes. 2013 May;62(5):1373-5. doi: 10.2337/db12-1839. No abstract available.

16.

Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity.

Lu C, Kumar PA, Sun J, Aggarwal A, Fan Y, Sperling MA, Lumeng CN, Menon RK.

J Biol Chem. 2013 May 31;288(22):15725-35. doi: 10.1074/jbc.M113.460212. Epub 2013 Apr 17.

17.

Infantile hypophosphatasia secondary to a novel compound heterozygous mutation presenting with pyridoxine-responsive seizures.

Belachew D, Kazmerski T, Libman I, Goldstein AC, Stevens ST, Deward S, Vockley J, Sperling MA, Balest AL.

JIMD Rep. 2013;11:17-24. doi: 10.1007/8904_2013_217. Epub 2013 Mar 12.

18.

Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype.

Flanagan SE, Mackay DJ, Greeley SA, McDonald TJ, Mericq V, Hassing J, Richmond EJ, Martin WR, Acerini C, Kaulfers AM, Flynn DP, Popovic J, Sperling MA, Hussain K, Ellard S, Hattersley AT.

Diabetologia. 2013 Jan;56(1):218-21. doi: 10.1007/s00125-012-2766-z. Epub 2012 Oct 31. No abstract available.

19.

Long-term therapy with growth hormone: bringing sagacity to SAGHE.

Sperling MA.

J Clin Endocrinol Metab. 2012 Jan;97(1):81-3. doi: 10.1210/jc.2011-3271. No abstract available.

PMID:
22223769
20.

Diabetic ketoacidosis: persistence and paradox.

Sperling MA.

Pediatr Diabetes. 2011 Jun;12(4 Pt 1):293-4. doi: 10.1111/j.1399-5448.2011.00787.x. No abstract available. Erratum in: Pediatr Diabetes. 2011 Aug;12(5):527.

PMID:
21615649
21.

Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice.

Mavalli MD, DiGirolamo DJ, Fan Y, Riddle RC, Campbell KS, van Groen T, Frank SJ, Sperling MA, Esser KA, Bamman MM, Clemens TL.

J Clin Invest. 2010 Nov;120(11):4007-20. doi: 10.1172/JCI42447.

22.

Preservation of beta cell function.

Sperling MA.

Pediatr Diabetes. 2010 May;11(3):152-3. doi: 10.1111/j.1399-5448.2010.00675.x. No abstract available.

PMID:
20546532
23.

A new decade.

Sperling MA.

Pediatr Diabetes. 2010 Feb;11(1):1. doi: 10.1111/j.1399-5448.2010.00643.x. No abstract available.

PMID:
20415725
24.

Research initiatives in neonatal hypoglycemia.

Thornton PS, Stanley CA, De León D, Kelly A, Sperling MA, Wolfsdorf JI, Hamond M.

J Pediatr. 2010 May;156(5):862-3; author reply 863. doi: 10.1016/j.jpeds.2010.01.048. Epub 2010 Mar 20. No abstract available.

PMID:
20304419
25.

A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation.

Lu C, Kumar PA, Fan Y, Sperling MA, Menon RK.

Endocrinology. 2010 May;151(5):2189-99. doi: 10.1210/en.2009-1194. Epub 2010 Feb 25.

26.

Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.

Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M, Sperling MA.

J Biol Chem. 2009 Jul 24;284(30):19937-44. doi: 10.1074/jbc.M109.014308. Epub 2009 May 21.

27.

Light at the end of the tunnel?

Sperling MA.

Pediatr Diabetes. 2008 Jun;9(3 Pt 2):1-3. doi: 10.1111/j.1399-5448.2008.00397.x. No abstract available.

PMID:
18540864
28.

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood.

Ize-Ludlow D, Gray JA, Sperling MA, Berry-Kravis EM, Milunsky JM, Farooqi IS, Rand CM, Weese-Mayer DE.

Pediatrics. 2007 Jul;120(1):e179-88.

PMID:
17606542
29.

Childhood diabetes mellitus: recent advances & future prospects.

Dejkhamron P, Menon RK, Sperling MA.

Indian J Med Res. 2007 Mar;125(3):231-50. Review.

PMID:
17496353
30.

Diabetic ketoacidosis.

Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee WR, Rosenbloom A, Sperling MA, Hanas R; International Society for Pediatric and Adolescent Diabetes.

Pediatr Diabetes. 2007 Feb;8(1):28-43. No abstract available.

PMID:
17341289
31.

The genetic basis of neonatal diabetes mellitus.

Sperling MA.

Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:71-5. Review.

PMID:
17261973
32.

PET scanning for infants with HHI: a small step for affected infants, a giant leap for the field.

Sperling MA.

J Pediatr. 2007 Feb;150(2):122-4. No abstract available.

PMID:
17236885
33.

Hypoglycemia in newborns and infants.

Dekelbab BH, Sperling MA.

Adv Pediatr. 2006;53:5-22. Review. No abstract available.

PMID:
17089861
34.

Recent advances in hyperinsulinemic hypoglycemia of infancy.

Dekelbab BH, Sperling MA.

Acta Paediatr. 2006 Oct;95(10):1157-64. Review.

PMID:
16982483
35.

Insulin-like peptide 6: characterization of secretory status and posttranslational modifications.

Lu C, Walker WH, Sun J, Weisz OA, Gibbs RB, Witchel SF, Sperling MA, Menon RK.

Endocrinology. 2006 Dec;147(12):5611-23. Epub 2006 Aug 24.

PMID:
16935843
36.

ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.

Sperling MA.

N Engl J Med. 2006 Aug 3;355(5):507-10. No abstract available.

PMID:
16885555
37.

Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association.

Wolfsdorf J, Glaser N, Sperling MA; American Diabetes Association.

Diabetes Care. 2006 May;29(5):1150-9. No abstract available.

PMID:
16644656
38.

Cerebral edema in diabetic ketoacidosis: an underestimated complication?

Sperling MA.

Pediatr Diabetes. 2006 Apr;7(2):73-4. No abstract available.

PMID:
16629711
39.

Metabolic consequences of prematurity.

Cutfield WS, Hofman PL, Sperling MA.

Expert Rev Endocrinol Metab. 2006 Mar;1(2):209-218. doi: 10.1586/17446651.1.2.209.

PMID:
30754134
40.

The classification of diabetes mellitus: a conceptual framework.

Ize-Ludlow D, Sperling MA.

Pediatr Clin North Am. 2005 Dec;52(6):1533-52.

PMID:
16301082
41.

Diabetes mellitus in children.

Sperling MA.

Pediatr Clin North Am. 2005 Dec;52(6):xv-xvi. No abstract available.

PMID:
16301081
42.

Neonatal diabetes mellitus: from understudy to center stage.

Sperling MA.

Curr Opin Pediatr. 2005 Aug;17(4):512-8. Review.

PMID:
16012265
43.

Diabetic ketoacidosis in children: the problems continue.

Sperling MA.

Pediatr Diabetes. 2005 Jun;6(2):67-8. No abstract available.

PMID:
15963031
44.

Prematurity--a window of opportunity?

Sperling MA.

N Engl J Med. 2004 Nov 18;351(21):2229-31. No abstract available.

PMID:
15548784
45.

Differential diagnosis and management of neonatal hypoglycemia.

Sperling MA, Menon RK.

Pediatr Clin North Am. 2004 Jun;51(3):703-23, x. Review.

PMID:
15157593
46.

Hyperinsulinemic hypoglycemia of infancy: the challenge continues.

Dekelbab BH, Sperling MA.

Diabetes Metab Res Rev. 2004 May-Jun;20(3):189-95. Review.

PMID:
15133749
47.

The expanding horizons of pediatric diabetes.

Sperling MA.

Pediatr Diabetes. 2004 Mar;5(1):1-2. No abstract available.

PMID:
15043682
48.

Limitations of first-phase insulin response to evaluate insulin secretion in children.

Cutfield WS, Menon RK, Bright GN, Sperling MA.

Pediatr Diabetes. 2000 Mar;1(1):3-9.

PMID:
15016236
49.

The end of the beginning.

Sperling MA.

Pediatr Diabetes. 2000 Sep;1(3):119-20. No abstract available.

PMID:
15016221
50.

Intra-uterine growth retardation and subsequent insulin secretion/action.

Sperling MA.

Pediatr Diabetes. 2000 Dec;1(4):179-80. No abstract available.

PMID:
15016212

Supplemental Content

Loading ...
Support Center